Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease

NCT06850597 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

MCI
MCI-AD, Early Stage Alzheimer's Disease
Alzheimer's Disease

Interventions

DRUG: dimethyl fumarate

Sponsor

Medical University of Lodz